title: [The use of melatonin in combined therapy of drug-induced hepatitis].
abstract: Combined treatment including melatonin resulted in the improvement of general conditions in 81.7% of the patients with drug-induced hepatitis compared with 66.5% after standard therapy including hepatoprotectors. Normalization of biochemical characteristics was more pronounced after treatment with melatonin that caused no side effects as shown by laboratory and instrumental studies.
authors.forename: S S
authors.initials: SS
authors.lastname: Popov
authors.forename: A N
authors.initials: AN
authors.lastname: Pashkov
authors.forename: V I
authors.initials: VI
authors.lastname: Zoloedov
authors.forename: G I
authors.initials: GI
authors.lastname: Shvedov
mesh_terms: D000328:Adult; D000368:Aged; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008550:Melatonin / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D008875:Middle Aged; D010936:Plant Extracts / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D010936:Plant Extracts; D008550:Melatonin